Posted on 5월 23, 20255/23/25
Most Favored Nation Pricing | Insights and Implications for Manufacturers
Posted on 5월 15, 20255/15/25
From Science to Value: Strategic Asset Valuation for Biotech Licensing and Fundraising
Posted on 5월 5, 20255/5/25
Harnessing the Digital Voice: High-Impact Social Listening for Pharma in the Diverse APAC Landscape
Posted on 4월 11, 20254/11/25
Unlocking Pharma Success: Mike Ryan’s Pre-Conference Talk at Reuters Pharma 2025
Posted on 4월 4, 20254/4/25
CASE STUDY: Transforming Clinical Trials with EVERSANA
Posted on 4월 3, 20254/3/25
Generic Substitution in Southeast Asia and Emerging Markets: Key Insights for Strategic Decision-Making
Posted on 4월 1, 20254/1/25
Escaping the Chronic Microcap Trap: How Launching Alone Is the Only Option for Growth
Posted on 3월 19, 20253/19/25
Maximizing Sales with AI: A Strategic Roadmap for Success
Posted on 3월 19, 20253/19/25
Rare Disease Care in India: A Path to Positive Impact
Posted on 2월 28, 20252/28/25